Nicotine decreases the cytotoxicity of doxorubicin towards MCF-7 and KB-3.1 human cancer cells in culture

Journal of the National Medical Association

Volumn 99, Issue 4, 2007, Pages 319-327

  Zhou, Yanfei ^a,b   Gu, Xinbin ^a,b   Ashayeri, Ebrahim ^a   Zhang, Renshu ^a,b   Sridhar, Rajagopalan ^a,b,c  

^a HOWARD UNIVERSITY   (United States)

^b HOWARD UNIVERSITY CANCER CENTER   (United States)

^c HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

Cancer; Chemotherapy; Doxorubicin; Nicotine

Indexed keywords

DOXORUBICIN; NICOTINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RISK; CELL DEATH; CELL STRAIN KB; CELL STRAIN MCF 7; CLONOGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; EVALUATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PASSIVE SMOKING; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CASPASE 8; CELL CULTURE TECHNIQUES; DOXORUBICIN; DRUG INTERACTIONS; FLOW CYTOMETRY; HUMANS; NECROSIS; NICOTINE; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 34247250885     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. U.S. Department of Health and Human Services, Office on Smoking and Health. The health consequences of smoking: Cancer: a report of the Surgeon General. Washington, DC: DHHS (P(1-47)HS) publication, no 82-50179; 1982;322.
2. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev. 2005;14:2287-2293.
3. Nair U, Bartsch H. Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer. IARC Sci Publ. 2001;154:271-290.
4. Johnson KC. Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer. 2005;117:619-628.
5. Lash TL, Aschengrau A. Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol. 1999;149:5-12.
6. Kropp S, Chang-Claude J. Active and passive smoking and risk of breast cancer by age 50 years among German women. Am J Epidemiol. 2002;156:616-626.
7. Lee HY, Oh SH, Woo JK, et al. Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. J Natl Cancer Inst. 2005;97:1695-1699.
8. Berger MR, Zeller WJ. Interaction of nicotine with anticancer treatment. Klin Wochenschr. 1988;66(suppl 11):127-133.
9. Onoda N, Nehmi A, Weiner D, et al. Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents. Head Neck. 2001;23:860-870.
10. Dasgupta P, Kinkade R, DeCook, et al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A. 2006;103:6332-6337.
11. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer. 2005;5:231-237.
12. Steel GG. The case against apoptosis. Acta Oncol. 2001;40:968-975.
13. Desai PB, Bhardwaj R, Damle B. Effect of tamoxifen on mitoxantrone cytotoxicity in drug-sensitive and multidrug-resistant MCF-7 cells. Cancer Chemother Pharmacol. 1995;36:368-372.
14. Connor CE, Burrows J, Hearps AC, et al. Cell cycle arrest of hematopoietic cell lines after treatment with ceramide is commonly associated with retinoblastoma activation. Cytometry. 2001;43:164-169.
15. Soeda J, Miyagawa S, Sano K, et al. Cytochrome c release into cytosol with subsequent caspase activation during warm ischemia in rat liver. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1115-1123.
16. Mu YM, Yanase T, Nishi Y, et al. Saturated FFAs, palmitic acid and stearic acid induce apoptosis in human granulosa cells. Endocrinology. 2001;142:3590-3597.
17. Alles K, Alley JC, Barrett R et al. Apoptosis: a general comment. FASEB J. 1991;5:2127-2128.
18. Hall EJ. Radiobiology for the Radiologist. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
19. Scott SL, Gumerlock PH, Beckett L, et al. Survival and cell cycle kinetics of human prostate cancer cell lines after single- and multifraction exposures to ionizing radiation. Int J Radiat Oncol Biol Phys. 2004;59:219-227.
20. Xin M, Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem. 2005;280:10781-10789.
21. Yanagihara K, Nii M, Numoto M, et al. Radiation-induced apoptotic death in human gastric epithelial tumor cells: correlation between mitotic death and apoptosis. Int J Radiat Biol. 1995;67:677-685.
22. Mimnaugh EG, Gram TE, Trush MA. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers. J Pharmacol Exp Ther. 1983;226:806-816.
23. Engineer FN, Sridhar R. Attenuation of daunorubicin-augmented microsomal lipid peroxidation and oxygen consumption by calcium channel antagonists. Biochem Biophys Res Commun. 1991;179:1101-1106.
24. Sridhar R, Dwivedi C, Anderson J, et al. Effects of verapamil on the acute toxicity of doxorubicin in vivo. J Natl Cancer Inst. 1992;84:1653-1660.
25. Mimnaugh EG, Trush MA, Gram TE. Enhancement of rat heart microsomal lipid peroxidation following doxorubicin treatment in vivo. Cancer Treat Rep. 1983;67:731-733.
26. Sinha BK, Trush MA, Kennedy KA, et al. Enzymatic activation and binding of adriamycin to nuclear DNA. Cancer Res. 1984;44:2892-2896.
27. Kotamraju S, Kalivendi SV, Konorev E, et al. Oxidant-induced iron signaling in doxorubicin-mediated apoptosis. Methods Enzymol. 2004;378:362-382.
28. Minotti G, Recalcati S, Menna P, et al. Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms. Methods Enzymol. 2004;378:340-361.
29. Zweier JL. Iron-mediated formation of an oxidized adriamycin free radical. Biochim Biophys Acta. 1985;839:209-213.
30. Xu X, Persson HL, Richardson DR. Molecular pharmacology of the interaction of anthracyclines with iron. Mol Pharmacol. 2005;68:261-271.
31. Bodley A, Liu LF, Israel M, et al. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Cancer Res. 1989;49:5969-5978.
32. Olson LE, Bedja D, Alvey SJ, et al. Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1. Cancer Res. 2003;63:6602-6606.
33. Forrest GL, Gonzalez B, Tseng W, et al. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxlcity in transgenic mice. Cancer Res. 2000;60:5158-5164.
34. Martin DS, Bertino JR, Koutcher JA. ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach. Cancer Res. 2000;60:6776-6783.
35. Jin Z, Gao F, Flagg T, et al. Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis. J Biol Chem. 2004;279: 23837-23844.
36. Sugano N, Ito K. Nicotine switches the form of H(2)O(2)-induced cell death from apoptosis to necrosis in U937 cells. Immunol Lett. 2000;72:163-166.
37. Newman MB, Arendash GW, Shytle RD, et al.Nicotine's oxidative and antioxidant properties in CNS. Life Sci. 2002;71:2807-2820.
38. Guan ZZ, Yu WF, Nordberg A. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem Int. 2003;43:243-249.
39. Dewar BJ, Bradford BU, Thurman RG. Nicotine increases hepatic oxygen uptake in the isolated perfused rat liver by inhibiting glycolysis. J Pharmacol Exp Ther. 2002;301:930-937.
40. McArdle HJ, Tysoe J. Effect of nicotine on transferrin binding and iron uptake by cultured rat placenta. J Cell Physiol. 1988;134:509-513.
41. Klugmann FB, Decorti G, Crivellato E, et al. Effect of lysosomotropic and membrane active substances on adriamycin uptake and histamine release. Anticancer Res. 1990;10:1571-1577.
42. Crowley-Weber CL, Dvorakova K, Crowley C, et al. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact. 2003;145:53-66.
43. Tsurutani J, Castillo SS, Brognard J, et al. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis. 2005;26:1182-1195.
44. Ravikumar R, Flora G, Geddes JW, et al. Nicotine attenuates oxidative stress, activation of redox-regulated transcription factors and induction of proinflammatory genes in compressive spinal cord trauma. Brain Res Mol Brain Res. 2004;124:188-198.
45. Mai H, May WS, Gao F, et al. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem. 2003;278:1886-1891.
46. Wu YP, Kita K, Suzuki N. Involvement of human heat shock protein 90 alpha in nicotine-induced apoptosis. Int J Cancer. 2002;100:37-42.
47. Jang MH, Shin MC, Jung SB, et al. Alcohol and nicotine reduce cell proliferation and enhance apoptosis in dentate gyrus. Neuroreport. 2002;13:1509-1513.
48. Garrido R, Mattson MP, Hennig B, et al. Nicotine protects against arachidonic-acid-induced caspase activation, cytochrome c release and apoptosis of cultured spinal cord neurons. J Neurochem. 2001;76:1395-1403.
49. Hakki A, Pennypacker K, Eidizadeh S, et al. Nicotine inhibition of apoptosis in murine immune cells. Exp Biol Med (Maywood). 2001;226:947-953.
50. Hakki A, Friedman H, Pross S. Nicotine modulation of apoptosis in human coronary artery endothelial cells. Int Immunopharmacol. 2002;2:1403-1409.
51. Benowitz NL, Jacob P III, Denaro C, Jenkins R. Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther. 1991;49:270-277.